Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Later this week, The George Institute for Global Health and the Entrepreneurship Centre will be hosting Big Change: Sustainable Healthcare for the 21st Century, a significant international event that will address the issues and challenges facing healthcare this century.

This meeting will involve selected group of high-profile politicians, academics, entrepreneurs, investors and journalists in an interactive programme of challenge and debate.

The healthcare challenge facing humanity is unprecedented. Current systems are not sustainable and the world requires a fundamentally different way to deliver healthcare to all who need it. All around the globe healthcare systems are struggling to meet the demands of growing and ageing populations that have high expectations of the healthcare they want to receive. This is particularly true in the developed world, but it is also evident in emerging markets such as India and China. These economies have created new middle class populations that have contributed to dramatic rises in the prevalence of non-communicable disease such as cancers, heart disease and diabetes. Not only that, but the poor still suffer from disease associated with poverty such as malaria, TB and HIV.

Big Change: Sustainable Healthcare for the 21st century takes place on the 22 and 23 November 2013, at the Saïd Business School.

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

AIMday in Women's Health - registration for academics now open

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.